IP Library Granted Patent US 8,241,273
Granted Patent B2
US 8,241,273 · App. 12/685,596 · Granted Aug 14, 2012

Method and devices for coagulation of tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,241,273
App. No.
12/685,596
Granted
Aug 14, 2012
Kind
B2
Abstract

Methods and devices described herein facilitate improved treatment of body organs.

Claims (33)

1. A method of coagulating cardiac tissue, where the cardiac tissue comprises a first cardiac surface and a second cardiac surface, where the second cardiac surface is on an opposite side of the cardiac tissue from the first cardiac surface, the method comprising:

positioning a first coagulation device adjacent to the first cardiac surface;

forming a first coagulation lesion along the first cardiac surface using the coagulation device such that the first coagulation lesion forms an electrical barrier that prevents an electrical impulse from propagating in cardiac tissue across the first coagulation lesion;

positioning a second device having at least one electromagnetic energy source adjacent to the second cardiac surface;

applying electromagnetic energy adjacent to the second cardiac surface using the electromagnetic energy source;

identifying a location of the electromagnetic energy through the cardiac tissue from the first cardiac surface to locate the second device; and

repositioning the second device at a target location on the second cardiac surface in response to the location of the first coagulation lesion.

2. The method of claim 1 , further comprising creating a second coagulation lesion along the second cardiac surface, where the second coagulation lesion extends the electrical barrier of the first coagulation lesion to form a contiguous lesion.

3. The method of claim 2 , where the second device further includes at least one coagulation source, such that creating the second coagulation lesion comprises creating the second coagulation lesion with the second device.

4. The method of claim 2 , further comprising advancing a second coagulation device to the target location to create the second coagulation lesion.

5. The method of claim 2 , where the second coagulation lesion creates the electrical barrier across cardiac tissue without dissecting a pericardial reflection.

6. The method of claim 2 , where the first coagulation device and the second device comprise opposite poles of an RF energy supply, and where energy flows between the first coagulation device and second device during application of the RF energy supply.

7. The method of claim 1 , where the first coagulation device comprises a device selected from the group consisting of an RF energy device, a laser device, an infrared heating device, a chemical ablation device, a cryogenic device, a microwave energy device, and a resistive heating device.

8. The method of claim 1 , where the electromagnetic energy comprises an energy selected from the group consisting of visible light, coherent light, ultraviolet light, magnetic energy, and electrical energy.

9. The method of claim 1 , where identifying the electromagnetic energy through the cardiac tissue from the first cardiac surface comprises placing a sensor device adjacent to the first cardiac surface where the sensor device measures the electromagnetic energy to determine a proximity between the second device and the sensor device.

10. The method of claim 1 , where the first cardiac surface comprises an epicardial surface and the second cardiac surface comprises an endocardial surface.

11. The method of claim 1 , where the first cardiac surface comprises an endocardial surface and the second cardiac surface comprises an epicardial surface.

12. The method of claim 1 , where the first coagulation device is advanced through a port or trocar positioned in a body and where the second device is advanced through a vascular path in the body.

13. The method of claim 12 , where the port or trocar is located in an abdominal wall of the body and the first coagulation device is advanced through the diaphragm.

14. The method of claim 12 , where no ports or trocars are positioned in a chest wall of the body.

15. The method of claim 12 , where the first coagulation device is positioned adjacent to the first cardiac surface without requiring deflation of a lung.

16. The method of claim 12 , where the port or trocar is located in a chest wall of the body and the first coagulation device is advanced through the diaphragm.

17. The method of claim 1 , further comprising advancing a scope into a body where the scope comprises at least one visualization element and where identifying the location of the electromagnetic energy through the cardiac tissue from the first cardiac surface to locate the second device comprises using the visualization element to identify the location of the electromagnetic energy.

18. A method of forming a contiguous coagulation lesion in a tissue of a heart on multiple but opposite atrial surfaces, the method comprising:

positioning a first coagulation device adjacent to an endocardial surface of the tissue;

forming an endocardial coagulation lesion with the first coagulation device;

determining a location on the epicardial surface of the tissue that corresponds to an end of the endocardial coagulation lesion formed on the endocardial surface;

positioning a second coagulation device at or near the location on the epicardial surface such that creating an epicardial coagulation lesion on the epicardial surface causes the lesions to overlap, intersect, and/or join to form the contiguous coagulation lesion such that an electrical impulse is prevented from flowing in the across the contiguous coagulation lesion.

19. A method of creating a cardiac coagulation pattern in cardiac tissue using a minimally invasive surgical technique, the method comprising:

positioning a first coagulation device adjacent to a first cardiac surface;

partially forming the cardiac coagulation pattern by applying energy to the first coagulation device to create at least a first plurality of coagulation lesions along the first cardiac surface, where the first plurality of coagulation lesions includes at least two spaced lesions to define a gap section of tissue such that an electrical impulse is able to flow between the two spaced lesions through the gap section of tissue;

positioning a second coagulation device adjacent to a second cardiac surface, where the second cardiac surface is on an opposite side of the first cardiac surface; and

fully forming the cardiac coagulation pattern by applying energy to the second coagulation device to create at least one bridging coagulation lesion to span the gap section of tissue along the second cardiac surface, where the bridging coagulation lesion prevents an electrical impulse from flowing across the gap section of tissue.

Assignments (13)
MERGER AND CHANGE OF NAME Recorded Jan 28, 2026
From: NCONTACT SURGICAL, INC.; SECOND PORTAL MERGER SUB, LLC
To: NCONTACT SURGICAL, LLC
Reel/Frame 073617/0340 →
SECURITY INTEREST Recorded Jan 10, 2024
From: ATRICURE, INC.; ATRICURE, LLC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066267/0896 →
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2024
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC; SENTREHEART LLC
Reel/Frame 066256/0797 →
SECURITY INTEREST Recorded Dec 18, 2018
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 047951/0496 →
SECOND AMENDED AND RESTATED JOINT INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 25, 2016
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 038520/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2016
From: NCONTACT SURGICAL, LLC
To: ATRICURE, INC.
Reel/Frame 038062/0392 →
RELEASE OF SECURITY INTEREST Recorded Feb 22, 2011
From: INTERSOUTH PARTNERS VI, L.P.; HARBERT VENTURE PARTNERS II, L.P.; HARBERT VENTURE PARTNERS (ANNEX FUND), LLC; MASSEY BURCH VENTURE FUND II, L.P.; TALL OAKS ABLATRICS PARTNERS, LP; HIPPO VENTURES, L.L.C.; FINISTERE-CHICAGO PARTNERS FUND I, L.P.; FINISTERE-OCEANIA PARTNERS FUND I, L.P.
To: NCONTACT SURGICAL, INC.
Reel/Frame 025841/0380 →
RELEASE OF SECURITY INTEREST Recorded Feb 21, 2011
From: DAUGHERTY, DENNIS
To: NCONTACT SURGICAL, INC.
Reel/Frame 025836/0648 →
RELEASE OF SECURITY INTEREST Recorded Feb 21, 2011
From: INTERSOUTH PARTNERS VI, L.P.; MASSEY BURCH VENTURE FUND II, L.P.; TALL OAKS ABLATRICS PARTNERS, LP; HIPPO VENTURES, L.L.C.; FINISTERE-CHICAGO PARTNERS FUND I, L.P.; FINISTERE-OCEANIA PARTNERS FUND I, L.P.; HARBERT VENTURE PARTNERS II, L.P.
To: NCONTACT SURGICAL, INC.
Reel/Frame 025837/0119 →
SECURITY AGREEMENT Recorded Aug 20, 2010
From: NCONTACT SURGICAL, INC.
To: INTERSOUTH PARTNERS VI, L.P.; HARBERT VENTURE PARTNERS II, L.P.; HARBERT VENTURE PARTNERS (ANNEX FUND), LLC; MASSEY BURCH VENTURE FUND II, L.P.; TALL OAKS ABLATRICS PARTNERS, LP; FINISTERE-CHICAGO PARTNERS FUND I L.P.; FINISTERE-OCEANIA PARTNERS FUND I L.P.; HIPPO VENTURES, L.L.C.
Reel/Frame 024864/0206 →
SECURITY AGREEMENT Recorded Jun 4, 2010
From: NCONTACT SURGICAL, INC.
To: INTERSOUTH PARTNERS VI, L.P.; HARBERT VENTURE PARTNERS II, L.P.; MASSEY BURCH VENTURE FUND II, L.P.; TALL OAKS ABLATRICS PARTNERS, LP; FINISTERE-CHICAGO PARTNERS FUND I L.P.; FINISTERE-OCEANIA PARTNERS FUND I L.P.; HIPPO VENTURES, L.L.C.
Reel/Frame 024483/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2010
From: WHAYNE, JAMES G.; FLEISCHMAN, SIDNEY D.; SICVOL, CHRISTOPHER W.
To: NCONTACT SURGICAL, INC.
Reel/Frame 024349/0563 →
SECURITY AGREEMENT Recorded Feb 12, 2010
From: NCONTACT SURGICAL, INC.
To: DAUGHERTY, DENNIS
Reel/Frame 023928/0240 →